Back to Search
SARAH EDGERTON, DO
DO
Obstetrics & Gynecology Physician
NPI: 1790270437IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
5101023869(MI)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
ROCKY VISTA UNIVERSITY COLLEGE OF OSTEOPATHIC MED
Class of 2018
Research & Publications (20)
Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
PMID 19440038·Cell Cycle·2009
7-preclinical
Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro.
PMID 19221498·Cell Cycle·2009
8-other
Prospects for future climate change and the reasons for early action.
PMID 19044154·J Air Waste Manag Assoc·2008
8-other
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
PMID 18824714·J Clin Oncol·2008
3-trial
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.
PMID 18676864·Cancer Res·2008
8-other
Prospects for future climate change and the reasons for early action.
PMID 18581806·J Air Waste Manag Assoc·2008
6-review
Influence of activation state of ErbB-2 (HER-2) on response to adjuvant cyclophosphamide, doxorubicin, and fluorouracil for stage II, node-positive breast cancer: study 8541 from the Cancer and Leukemia Group B.
PMID 18390970·J Clin Oncol·2008
2-rct
HER2 and response to paclitaxel in node-positive breast cancer.
PMID 17928597·N Engl J Med·2007
4-observational
Downregulation of erbB3 abrogates erbB2-mediated tamoxifen resistance in breast cancer cells.
PMID 17266042·Int J Cancer·2007
7-preclinical
Caspase-3 mediated feedback activation of apical caspases in doxorubicin and TNF-alpha induced apoptosis.
PMID 17013758·Apoptosis·2006
8-other
Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
PMID 16168116·Breast Cancer Res·2005
7-preclinical
Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy.
PMID 15870885·Int J Oncol·2005
8-other
Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
PMID 15718311·J Clin Oncol·2005
8-other
Access to communication technologies in a sample of cancer patients: an urban and rural survey.
PMID 15717933·BMC Cancer·2005
8-other
Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention.
PMID 15705886·Cancer Res·2005
7-preclinical
Perinucleolar compartment prevalence has an independent prognostic value for breast cancer.
PMID 15665301·Cancer Res·2005
8-other
Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.
PMID 15020608·J Clin Oncol·2004
3-trial
erbB-2 (HER-2) and breast cancer progression.
PMID 12966347·Appl Immunohistochem Mol Morphol·2003
8-other
Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice.
PMID 12750262·Cancer Res·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5900 BYRON CENTER AVE SW
WYOMING, MI 49519 - Phone
- (616) 252-7604
Quick Facts
- NPI
- 1790270437
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile